Literature DB >> 26787771

5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and Antagonists.

Jennifer L Harmon1, Lauren P Wills1, Caitlin E McOmish1, Elena Y Demireva1, Jay A Gingrich1, Craig C Beeson1, Rick G Schnellmann2.   

Abstract

In acute organ injuries, mitochondria are often dysfunctional, and recent research has revealed that recovery of mitochondrial and renal functions is accelerated by induction of mitochondrial biogenesis (MB). We previously reported that the nonselective 5-HT2 receptor agonist DOI [1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine] induced MB in renal proximal tubular cells (RPTCs). The goal of this study was to determine the role of 5-HT2 receptors in the regulation of mitochondrial genes and oxidative metabolism in the kidney. The 5-HT2C receptor agonist CP-809,101 [2-[(3-chlorophenyl)methoxy]-6-(1-piperazinyl)pyrazine] and antagonist SB-242,084 [6-chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxyamide dihydrochloride] were used to examine the induction of renal mitochondrial genes and oxidative metabolism in RPTCs and in mouse kidneys in the presence and absence of the 5-HT2C receptor. Unexpectedly, both CP-809,101 and SB-242,084 increased RPTC respiration and peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) mRNA expression in RPTCs at 1-10 nM. In addition, CP-809,101 and SB-242,084 increased mRNA expression of PGC-1α and the mitochondrial proteins NADH dehydrogenase subunit 1 and NADH dehydrogenase (ubiquinone) β subcomplex 8 in mice. These compounds increased mitochondrial genes in RPTCs in which the 5-HT2C receptor was downregulated with small interfering RNA and in the renal cortex of mice lacking the 5-HT2C receptor. By contrast, the ability of these compounds to increase PGC-1α mRNA and respiration was blocked in RPTCs treated with 5-HT2A receptor small interfering RNA or the 5-HT2A receptor antagonist eplivanserin. In addition, the 5-HT2A receptor agonist NBOH-2C-CN [4-[2-[[(2-hydroxyphenyl)methyl]amino]ethyl]-2,5-dimethoxybenzonitrile] increased RPTC respiration at 1-100 nM. These results suggest that agonism of the 5-HT2A receptor induces MB and that the classic 5-HT2C receptor agonist CP-809,101 and antagonist SB-242,084 increase mitochondrial genes and oxidative metabolism through the 5-HT2A receptor. To our knowledge, this is the first report that links 5-HT2A receptor agonism to mitochondrial function. U.S. Government work not protected by U.S. copyright.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26787771      PMCID: PMC4809314          DOI: 10.1124/jpet.115.228395

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  42 in total

1.  6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist.

Authors:  S M Bromidge; M Duckworth; I T Forbes; P Ham; F D King; K M Thewlis; F E Blaney; C B Naylor; T P Blackburn; G A Kennett; M D Wood; S E Clarke
Journal:  J Med Chem       Date:  1997-10-24       Impact factor: 7.446

2.  Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.

Authors:  A L Killam; S S Nikam; G M Lambert; A R Martin; D L Nelson
Journal:  J Pharmacol Exp Ther       Date:  1990-03       Impact factor: 4.030

3.  Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome.

Authors:  Michael V Morabito; Atheir I Abbas; Jennifer L Hood; Robert A Kesterson; Michelle M Jacobs; David S Kump; David L Hachey; Bryan L Roth; Ronald B Emeson
Journal:  Neurobiol Dis       Date:  2010-04-13       Impact factor: 5.996

4.  Glycine-protected, hypoxic, proximal tubules develop severely compromised energetic function.

Authors:  J M Weinberg; N F Roeser; J A Davis; M A Venkatachalam
Journal:  Kidney Int       Date:  1997-07       Impact factor: 10.612

5.  PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function.

Authors:  Taiji Tsunemi; Travis D Ashe; Bradley E Morrison; Kathryn R Soriano; Jonathan Au; Ruben A Vázquez Roque; Eduardo R Lazarowski; Vincent A Damian; Eliezer Masliah; Albert R La Spada
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

6.  Characterization of a putative intrarenal serotonergic system.

Authors:  Jie Xu; Bing Yao; Xiaofeng Fan; Melissa M Langworthy; Ming-Zhi Zhang; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-22

7.  cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury.

Authors:  Ryan M Whitaker; Lauren P Wills; L Jay Stallons; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2013-09-16       Impact factor: 4.030

8.  Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling.

Authors:  Canan G Nebigil; Nelly Etienne; Nadia Messaddeq; Luc Maroteaux
Journal:  FASEB J       Date:  2003-05-08       Impact factor: 5.191

9.  The effects of the selective 5-HT(2C) receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats.

Authors:  Paul V Strong; Benjamin N Greenwood; Monika Fleshner
Journal:  Psychopharmacology (Berl)       Date:  2008-11-27       Impact factor: 4.530

10.  5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.

Authors:  M N Garnovskaya; C G Nebigil; J M Arthur; R F Spurney; J R Raymond
Journal:  Mol Pharmacol       Date:  1995-08       Impact factor: 4.436

View more
  8 in total

Review 1.  Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD.

Authors:  Hazel H Szeto
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

2.  5-HT1F receptor regulates mitochondrial homeostasis and its loss potentiates acute kidney injury and impairs renal recovery.

Authors:  Whitney S Gibbs; Justin B Collier; Morgan Morris; Craig C Beeson; Judit Megyesi; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-30

Review 3.  Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

Authors:  Robert B Cameron; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

4.  Identification of dual mechanisms mediating 5-hydroxytryptamine receptor 1F-induced mitochondrial biogenesis.

Authors:  Whitney S Gibbs; Sara M Garrett; Craig C Beeson; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2017-10-18

Review 5.  Psychedelic-inspired approaches for treating neurodegenerative disorders.

Authors:  Hannah N Saeger; David E Olson
Journal:  J Neurochem       Date:  2021-12-05       Impact factor: 5.546

6.  Regulatory mechanism of CCN2 production by serotonin (5-HT) via 5-HT2A and 5-HT2B receptors in chondrocytes.

Authors:  Ayaka Hori; Takashi Nishida; Shogo Takashiba; Satoshi Kubota; Masaharu Takigawa
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

7.  Serotonin regulates mitochondrial biogenesis and function in rodent cortical neurons via the 5-HT2A receptor and SIRT1-PGC-1α axis.

Authors:  Sashaina E Fanibunda; Sukrita Deb; Babukrishna Maniyadath; Praachi Tiwari; Utkarsha Ghai; Samir Gupta; Dwight Figueiredo; Noelia Weisstaub; Jay A Gingrich; Ashok D B Vaidya; Ullas Kolthur-Seetharam; Vidita A Vaidya
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-09       Impact factor: 11.205

Review 8.  5-HT Receptors and Temperature Homeostasis.

Authors:  Irina P Voronova
Journal:  Biomolecules       Date:  2021-12-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.